Skip to search.
 NZX 50 Up 1.17%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
10.40 Up 0.21(2.06%) 30 May 08:00
|After Hours : 10.40 0.00 (0.00%) 30 May 08:39
Add to Portfolio
Prev Close:10.19
Open:10.15
Bid:10.20 x 100
Ask:10.76 x 800
1y Target Est:21.60
Beta:5.19
Earnings Date:5 Aug - 10 Aug (Est.)
Day's Range:10.08 - 10.80
52wk Range:8.84 - 18.48
Volume:1,844,505
Avg Vol (3m):1,769,470
Market Cap:1.08b
P/E (ttm):N/A
EPS (ttm):-1.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KERXUp 2.06%1.08b
BAXDown 0.80%36.20b
SHPGUp 0.13%51.08b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):527.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.91
Quarterly EPS Est (Jun-15) :-0.26
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback